Source: Archives of clinical psychiatry. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, COMPROMETIMENTO COGNITIVO LEVE, AMINAS (COMPOSTOS ORGÂNICOS), PLASMA, BIOMARCADORES, IDOSOS
ABNT
JOAQUIM, Helena P. G et al. Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients. Archives of clinical psychiatry, v. 46, n. 5, p. 120-124, 2019Tradução . . Disponível em: https://doi.org/10.1590/0101-60830000000209. Acesso em: 03 nov. 2024.APA
Joaquim, H. P. G., Costa, A. C., Forlenza, O. V., Gattaz, W. F., & Talib, L. L. (2019). Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients. Archives of clinical psychiatry, 46( 5), 120-124. doi:10.1590/0101-60830000000209NLM
Joaquim HPG, Costa AC, Forlenza OV, Gattaz WF, Talib LL. Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients [Internet]. Archives of clinical psychiatry. 2019 ; 46( 5): 120-124.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1590/0101-60830000000209Vancouver
Joaquim HPG, Costa AC, Forlenza OV, Gattaz WF, Talib LL. Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients [Internet]. Archives of clinical psychiatry. 2019 ; 46( 5): 120-124.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1590/0101-60830000000209